Latest DEF 14A proxy statements
NASDAQ
iRhythm Holdings, Inc. announces its 2026 Annual Meeting of Stockholders to vote on director elections, a new equity incentive plan, and corporate governance amendments.
NASDAQ
indie Semiconductor, Inc. has issued its 2026 Proxy Statement detailing proposals for director elections, executive compensation, and an increase in equity plan shares.
NASDAQ
Waystar Holding Corp. reports strong 2025 financial performance, surpassing $1 billion in revenue, and outlines governance and compensation updates ahead of its 2026 Annual Meeting.
NYSE
Otis Worldwide Corporation reports solid 2025 financial performance driven by service and modernization growth, alongside significant corporate governance enhancements and executive compensation reforms.
NASDAQ
Aveanna Healthcare Holdings Inc. announces strong fiscal year 2025 results, including significant revenue and Adjusted EBITDA growth, completion of its Strategic Transformation, and a major debt refinancing.
NASDAQ
Relmada Therapeutics is seeking shareholder approval to increase authorized shares and equity incentives following a strategic turnaround and $100 million capital raise.
NYSE
MFA Financial highlights a significant increase in net income to $176.8 million for 2025 while proposing director elections and executive compensation approvals for its upcoming annual meeting.
NYSE
Artisan Partners Asset Management Inc. announces its 2026 Annual Meeting of Stockholders to be held virtually on June 3, 2026.
NYSE
Morgan Stanley Direct Lending Fund announces its 2026 Annual Meeting of Stockholders to be held virtually on June 1, 2026.
NYSE
American Integrity Insurance Group, Inc. has issued its 2026 proxy statement detailing director elections, executive compensation, and auditor ratification.
NYSE
Western Asset Premier Bond Fund has scheduled its annual meeting of shareholders for May 21, 2026, to elect ten trustees to the board.
NYSE
CARS
Carscom INCCars.com Inc. schedules its 2026 Annual Meeting for June 3, 2026, and confirms the leadership transition to new CEO Tobias Hartmann.
NYSE
Western Asset Investment Grade Income Fund Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders scheduled for May 21, 2026.
NYSE
Western Asset Inflation-Linked Income Fund has scheduled its annual meeting of shareholders for May 21, 2026, to elect four Class II Trustees.
NASDAQ
NSTS Bancorp, Inc. announces its 2026 Annual Meeting of Stockholders to be held on May 27, 2026, to elect directors and ratify its independent auditor.
NYSE
Western Asset Inflation-Linked Opportunities & Income Fund has scheduled its 2026 Annual Meeting of Shareholders for May 21, 2026, to elect three Class I Trustees.
NYSE
Vitesse Energy, Inc. has released its 2026 proxy statement detailing director elections, executive leadership transitions, and auditor ratification.
NASDAQ
Public Policy Holding Company, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and electronic communication proposals.
NASDAQ
Banzai International has scheduled a special meeting for April 28, 2026, to seek shareholder approval for a reverse stock split of up to 1-for-20 to maintain Nasdaq listing compliance.
NYSE
Douglas Emmett, Inc. has filed its 2026 proxy statement, seeking shareholder approval for a new omnibus stock incentive plan and the election of eight directors.
NASDAQ
Summit Therapeutics Inc. has issued its 2026 proxy statement detailing proposals for director elections, auditor ratification, executive compensation, and a stock incentive plan amendment.
NASDAQ
Chime Financial, Inc. has filed its 2026 proxy statement detailing proposals for its upcoming annual meeting, including director elections and executive compensation.
NASDAQ
Nauticus Robotics seeks shareholder approval for a reverse stock split, an increase in authorized shares, and an expansion of its equity incentive plan.
NASDAQ
Oruka Therapeutics schedules its 2026 Annual Meeting of Stockholders for June 2, 2026, to address director elections, auditor ratification, and executive compensation.
NASDAQ
Corcept Therapeutics has issued its 2026 proxy statement detailing director elections, executive compensation, and a proposal to increase shares under its 2024 Incentive Award Plan.
NASDAQ
DUOL
Duolingo, INCDuolingo, Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, auditor ratification, and executive compensation, following a year of record bookings and revenue in 2025.
NYSE
ETSY
Etsy INCEtsy's 2026 proxy statement outlines a leadership transition to CEO Kruti Patel Goyal and proposes an increase in shares for the 2024 Equity Incentive Plan.
NASDAQ
CYTK
Cytokinetics INCCytokinetics, Inc. has issued its 2026 Proxy Statement detailing proposals for the upcoming Annual Meeting of Stockholders on May 27, 2026.
NYSE
Intrepid Potash, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation proposals.
NASDAQ
PROK
Prokidney CORPProKidney Corp. has issued its proxy statement for the 2026 annual meeting of stockholders to be held on May 28, 2026.